The Trp64Arg mutation of the beta 3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec family study and Swedish obese subjects cohorts

被引:128
作者
Gagnon, J
Mauriege, P
Roy, S
Sjostrom, D
Chagnon, YC
Dionne, FT
Oppert, JM
Perusse, L
Sjostrom, L
Bouchard, C
机构
[1] UNIV LAVAL,PHYS ACT SCI LAB,ST FOY,PQ G1K 7P4,CANADA
[2] GOTHENBURG UNIV,DEPT MED,SAHLGRENSKA HOSP,GOTHENBURG,SWEDEN
关键词
mutation; diabetes; linkage; body fat; visceral fat;
D O I
10.1172/JCI119014
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The beta adrenergic system plays a key role in regulating energy balance through the stimulation of both thermogenesis and lipid mobilization in brown and white adipose tissues in human and various animal models, Recent studies have suggested that a missense Trp64Arg mutation in the beta 3 adrenergic receptor (ADRB3) gene was involved in obesity and insulin resistance. We have investigated the effect of this mutation on obesity-related phenotypes in two cohorts: the Quebec Family Study (QFS) and the Swedish Obese Subjects (SOS), In QFS, no association was found between this mutation and body mass index (BMI), body fat including abdominal visceral fat, resting metabolic rate, various diabetes and cardiovascular risk factors, and changes in body weight and body fat over a 12-yr period. With the exception of RMR (P=0.04), no evidence of linkage was detected between the mutation and phenotypes of QFS based on sib-pair data. In SOS, the frequency of the Trp64Arg allele was not significantly different between nonobese and obese female subjects and no association was found between the mutation and body weight gain over time. These findings do not support the view that there is an association between the Trp64Arg mutation in the ADRB3 gene and obesity.
引用
收藏
页码:2086 / 2093
页数:8
相关论文
共 55 条
  • [41] PIETRIROUXEL F, 1995, EUR J BIOCHEM, V230, P350, DOI 10.1111/j.1432-1033.1995.tb20570.x
  • [42] REDUCED RATE OF ENERGY-EXPENDITURE AS A RISK FACTOR FOR BODY-WEIGHT GAIN
    RAVUSSIN, E
    LILLIOJA, S
    KNOWLER, WC
    CHRISTIN, L
    FREYMOND, D
    ABBOTT, WGH
    BOYCE, V
    HOWARD, BV
    BOGARDUS, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (08) : 467 - 472
  • [43] RICHTERICH R, 1971, SCHWEIZ MED WSCHR, V101, P615
  • [44] LACK OF BETA(3)-ADRENERGIC EFFECT ON LIPOLYSIS IN HUMAN SUBCUTANEOUS ADIPOSE-TISSUE
    ROSENBAUM, M
    MALBON, CC
    HIRSCH, J
    LEIBEL, RL
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 77 (02) : 352 - 355
  • [45] SIRI W E, 1956, Adv Biol Med Phys, V4, P239
  • [46] SJOSTROM L, 1992, INT J OBESITY, V16, P465
  • [47] Structure, function, and regulation of the three beta-adrenergic receptors
    Strosberg, AD
    [J]. OBESITY RESEARCH, 1995, 3 : S501 - S505
  • [48] TARGETED DISRUPTION OF THE BETA(3)-ADRENERGIC RECEPTOR GENE
    SUSULIC, VS
    FREDERICH, RC
    LAWITTS, J
    TOZZO, E
    KAHN, BB
    HARPER, ME
    HIMMSHAGEN, J
    FLIER, JS
    LOWELL, BB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (49) : 29483 - 29492
  • [49] Tavernier G, 1996, J LIPID RES, V37, P87
  • [50] Van Liefde Isabelle, 1994, Life Sciences, V54, P209